TAZ Reduces UVA-mediated Photoaging through Regulates Cell Proliferation in Skin Fibroblasts

Area of Science:

• Dermatology
• Molecular Biology
• Cell Biology

Background:

• The Hippo pathway and its downstream transcription factor TAZ regulate critical cellular processes including proliferation and apoptosis.
• Photoaging, driven by UV radiation, is a significant concern in dermatology, leading to skin damage and aging.
• Understanding the molecular mechanisms underlying photoaging is crucial for developing effective interventions.

Purpose of the Study:

• To investigate the role of TAZ in response to UVA-induced photoaging in skin fibroblasts.
• To elucidate the molecular changes associated with TAZ expression under chronic UVA irradiation.
• To determine if TAZ can serve as a therapeutic target for photoaging.

Main Methods:

• Exposure of human skin fibroblasts to repeated UVA irradiation.
• Assessment of TAZ, CTGF, P16, P21, Lamin B1, and Lamin A/C expression at mRNA and protein levels.
• Cell proliferation assays, DNA damage assessment, and cell cycle analysis.
• Manipulation of TAZ expression through overexpression and subsequent UVA exposure.

Main Results:

• Continuous UVA irradiation decreased TAZ and CTGF expression, reduced cell proliferation, and induced DNA damage and cell cycle arrest.
• UVA exposure increased P16 and P21 expression while decreasing Lamin B1 and Lamin A/C.
• TAZ reduction was found to promote UVA-induced photoaging in fibroblasts.
• TAZ overexpression initially reduced cell cycle arrest markers but failed to protect against chronic UVA exposure, which re-induced these markers.

Conclusions:

• TAZ plays a protective role against photoaging in skin fibroblasts.
• TAZ expression is downregulated by chronic UVA irradiation, contributing to photoaging.
• TAZ represents a potential therapeutic target for mitigating photoaging and UVA-related skin disorders.